MSX-3 is an A2A adenosine receptor antagonist and a prodrug of MSX-2. References: Agosto-Marlin IM, Nichols NL, Mitchell GS. Adenosine-dependent phrenic motor facilitation is inflammation resistant. J Neurophysiol. 2017 Feb 1;117(2):836-845. doi: 10.1152/jn.00619.2016. Epub 2016 Dec 7. PubMed PMID: 27927784; PubMed Central PMCID: PMC5315699.

纯度：≥98%

CAS：261717-23-1